Search

Your search keyword '"Aldersley, Mark"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Aldersley, Mark" Remove constraint Author: "Aldersley, Mark"
47 results on '"Aldersley, Mark"'

Search Results

3. FRI-374-YI The UK experience of liver transplantation for HBV: excellent clinical outcomes despite a significant burden of HBV/Delta disease and wide variation in hepatitis B immunoglobulin prophylaxis practices-time for a consistent approach?

4. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

5. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

6. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

7. Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study

8. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

9. Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK

10. Excess mortality risk among hepatitis C patients after being “cured” in the interferon-free era: results from three population-based cohorts

11. Additional file 1 of Universal testing for hepatitis B and hepatitis C in the emergency department: a cost-effectiveness and budget impact analysis of two urban hospitals in the United Kingdom

12. The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis

13. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

14. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

15. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

23. Reply to: “Reply to: ‘Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries’”

24. OS005 - Excess mortality risk among hepatitis C patients after being “cured” in the interferon-free era: results from three population-based cohorts

25. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581]

28. Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy

29. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

30. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

31. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

34. Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.

35. Liver transplant listing for hepatitis C‐associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct‐acting antiviral therapy.

36. Patient understanding of liver cirrhosis and improvement using multimedia education

45. Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

46. Patient understanding of liver cirrhosis and improvement using multimedia education

47. International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

Catalog

Books, media, physical & digital resources